Patents by Inventor Michael John Rathbone

Michael John Rathbone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230049584
    Abstract: A device for insertion into a cavity, such as the vagina of a mammal, the device comprising a body for insertion into the cavity comprising a variable geometry retention mechanism, one or more active-impregnated matrices supported by the body, the matrix or matrices having (i) a ratio of exposed surface area to volume of 11.5:1 to 18.5:1, or (ii) a ratio of exposed surface area to weight of 11:1 to 17:1, or (iii) both (i) and (ii).
    Type: Application
    Filed: February 9, 2021
    Publication date: February 16, 2023
    Inventor: Michael John RATHBONE
  • Publication number: 20080317820
    Abstract: A control release device for the delivery of active components, the device including; a rigid housing containing at least one discrete aperture therein, and a driving substance containing the active component(s) placed within the housing, characterized in that the driving substance swells in the presence of fluid, driving the substance and active components out of the housing through the apertures.
    Type: Application
    Filed: October 26, 2006
    Publication date: December 25, 2008
    Applicant: INTERAG
    Inventors: Michael John Rathbone, Wade Jeffrey Mace, Keith James Ellis
  • Patent number: 7083590
    Abstract: A device suitable for use as an intra vaginal device or as a bolus where, after initiation, a member (usually a plunger) moves with a known movement characteristic and is involved in the stagger release of multiple materials. That moving member is used to time the discharge of one or more material from its reservoir in the device (there being separate powering of the timed discharge) or is used to both time and indirectly power the discharge of one or more material from its reservoir, such discharges preferably being in a staggered manner. Optionally the moving member as a plunger may itself also directly discharge a material from a reservoir.
    Type: Grant
    Filed: August 9, 2000
    Date of Patent: August 1, 2006
    Assignee: Interag
    Inventors: Craig Robert Bunt, Michael John Rathbone, Shane Burggraaf, Colin Roger Ogle
  • Patent number: 6776164
    Abstract: A biodegradable intra vaginal device for insertion into the vagina of an animal (eg; cattle) useful for herd oestrus synchrony purposes, the device is intra vaginally insertable, intra vaginally retainable and withdrawable by virtue of its ability to change its geometry yet is formed at least almost exclusively from a cyclodextrin and progesterone impregnated moulded matrix of a polyester polymer (eg; poly (&egr;-caprolactone)) or a starch-like polysaccharide polymer. There is preferably a loading of progesterone of from 0.1 to 3 gms. The surface area of the impregnated matrix is preferably from 15 to 200 cm2. Related methods and uses also form part of the invention.
    Type: Grant
    Filed: December 5, 2000
    Date of Patent: August 17, 2004
    Assignee: Interag
    Inventors: Craig Robert Bunt, Michael John Rathbone, Shane Burggraaf
  • Publication number: 20040142012
    Abstract: A passive or active release device for a medicament or other substance for a target species mammal. The device is of a kind capable of being inserted into a body cavity of a target species mammal and deploying resiliently to one or more retention condition(s). The device is wholly or in part moulded from poly (-caprolactone) (optionally impregnated with at least a physiologically effective agent to be released therefrom or optionally to carry some device or material to be body cavity retained at least for a period). The device is preferably of substantially a “T” or “Y” shape.
    Type: Application
    Filed: March 14, 2004
    Publication date: July 22, 2004
    Inventors: Craig Robert Bunt, Michael John Rathbone, Colin Roger Ogle, Mark Andrew Wyllie
  • Patent number: 6663608
    Abstract: An intra vaginal device which is of a variable geometry and which includes a silicone matrix impregnated with progesterone, the confirmation and content of the progesterone impregnated matrix being such as to optimise effectiveness with a lower initial loading of progesterone.
    Type: Grant
    Filed: October 11, 2001
    Date of Patent: December 16, 2003
    Assignee: Interag
    Inventors: Michael John Rathbone, Craig Robert Bunt, Shane Burggaaf
  • Publication number: 20030007994
    Abstract: Intra-vaginal delivery procedures including compositions and units therefor whereby an effective releasable amount of oestradiol 17&bgr; is released to achieve an efficacious effect insofar as oestrus expression is concerned. Preferably a cyclodextrin is utilized to enhance absorption.
    Type: Application
    Filed: June 3, 2002
    Publication date: January 9, 2003
    Applicant: INTERAG.
    Inventors: Craig Robert Bunt, Michael John Rathbone, Shane Burggraaf
  • Patent number: 6450991
    Abstract: A device for actively releasing material(s) (e.g. intra ruminally) having a plurality of dispensing reservoirs. Each electrolytic cell is capable upon energization under the control of a microprocessor after initiation of generating a gas which will cause (e.g. through action on a piston) by displacement of the material(s) of its respective reservoir sufficient displacement of or change to closure means of that reservoir thereby to allow release of the material(s).
    Type: Grant
    Filed: July 14, 2000
    Date of Patent: September 17, 2002
    Assignee: Interag
    Inventors: Craig Robert Bunt, Michael John Rathbone, Shane Burggraaf
  • Patent number: 6444224
    Abstract: Disclosed herein is a porcine intra-vaginal device of a shape and size adapted to be positionable in the vaginal tract across the hymenal ring of a target animal (e.g., a gilt) to extend to both sides of the hymenal ring of the animal. The device once inserted delivers progesterone from a progesterone impreganated matrix on either side of the hymenal ring, the progesterone releasing surface being at least 150 cm2 in total area. Variable geometry means (preferably for vestibular engagement) ensure retention of the devices (e.g., for at least 7 to 14 days) where, in the preferred device, the progesterone load of from 1.9 to 2.5 g within 1.2 mm of the release surface can, by maintaining a progesterone blood plasma level (equating to a progestrone blood plasma level in excess of 4 ng/mL measured in an ovariectomised animal), ensure or prompt the onset of oestrus within 3 to 5 days after device removal.
    Type: Grant
    Filed: March 2, 2000
    Date of Patent: September 3, 2002
    Assignee: Interag
    Inventors: Michael John Rathbone, Shane Burccraff, James Frederick Pharaoh
  • Patent number: 6423039
    Abstract: An intra vaginal device which is of a variable geometry and which includes a silicone matrix impregnated with progesterone, the confirmation and content of the progesterone impregnated matrix being such as to optimize effectiveness with a lower initial loading of progesterone.
    Type: Grant
    Filed: October 30, 1998
    Date of Patent: July 23, 2002
    Assignee: Interag
    Inventors: Michael John Rathbone, Craig Robert Bunt, Shane Burggraaf
  • Publication number: 20020058926
    Abstract: An intra vaginal device which is of a variable geometry and which includes a silicone matrix impregnated with progesterone, the confirmation and content of the progesterone impregnated matrix being such as to optimize effectiveness with a lower initial loading of progesterone.
    Type: Application
    Filed: October 11, 2001
    Publication date: May 16, 2002
    Applicant: INTERAG
    Inventors: Michael John Rathbone, Craig Robert Bunt, Shane Burggraaf
  • Publication number: 20020028788
    Abstract: Intra-vaginal delivery procedures including compositions and units therefor whereby an effective releasable amount of oestradiol 17&bgr; is released to achieve an efficacious effect insofar as oestrus expression is concerned. Preferably a cyclodextrin is utilized to enhance absorption.
    Type: Application
    Filed: December 18, 2000
    Publication date: March 7, 2002
    Inventors: Craig Robert Bunt, Michael John Rathbone, Shane Burggraaf
  • Patent number: 6352524
    Abstract: A delivery device having a reservoir of variable volume having an outlet through which an included vehicle can be expressed in a liquid form as the volume of the reservoir is actively reduced. There is a tube providing a conduit to the outlet from the reservoir of such length and cross-section as to favor active release over passive release which has the effect of enabling a more positive control of the dispensing of the vehicle. Such a device has diverse applications.
    Type: Grant
    Filed: December 9, 1998
    Date of Patent: March 5, 2002
    Assignee: Interag
    Inventors: Craig Robert Bunt, Michael John Rathbone, Shane Burggraaf
  • Publication number: 20020026158
    Abstract: An intra vaginal device which is of a variable geometry kind and which includes a silicone matrix impregnated with progesterone, the confirmation and content of the progesterone impregnated matrix being such as to optimize effectiveness with a lower initial loading of progesterone.
    Type: Application
    Filed: October 30, 1998
    Publication date: February 28, 2002
    Inventors: MICHAEL JOHN RATHBONE, CRAIG ROBERT BUNT, SHANE BURGGRAAF
  • Publication number: 20010029357
    Abstract: A biodegradable intra vaginal device for insertion into the vagina of an animal (eg; cattle) useful for herd oestrus synchrony purposes,
    Type: Application
    Filed: December 5, 2000
    Publication date: October 11, 2001
    Inventors: Craig Robert Bunt, Michael John Rathbone, Shane Burggraaf